share_log

United Imaging Healthcare Announces Q3 2024 Results With Revenue of January to September of 6.95 Billion CNY

United Imaging Healthcare Announces Q3 2024 Results With Revenue of January to September of 6.95 Billion CNY

联影医疗宣布2024年第三季度业绩,营业收入从一月至九月达到69.5亿人民币
PR Newswire ·  11/04 01:29

SHANGHAI, Nov. 4, 2024 /PRNewswire/ -- United Imaging Healthcare (SSE: 688271), a global leader in manufacturing advanced medical imaging and radiotherapy equipment, announced its financial results for the third quarter of 2024. Reflecting its development strategy and strategic R&D investments, the company reported that revenue of January to September is 6.95 billion CNY, with net income attributable to shareholders reaching 0.67 billion CNY.

上海,2024年11月4日 / PRNewswire / - 联影医疗(SSE:688271),全球医疗影像和放射治疗设备制造领导者,宣布2024年第三季度的财务业绩。反映其发展策略和战略研发投资,公司报告显示,1月至9月份的营业收入为69.5亿人民币,归属股东的净利润达到6.7亿人民币。

In 2024, United Imaging Healthcare has significantly increased its R&D efforts to pioneer high-end medical technologies and support the digital transformation of healthcare institutions. To date, over ten innovative United Imaging Healthcare products have received market approval,* including:

2024年,联影医疗大幅增加了研发投入,致力于开拓高端医疗技术,支持医疗机构的数字化转型。至今,联影医疗已经获得市场批准的十多个创新产品,包括:

  • uLinac HalosTx, an integrated CT circular linear accelerator
  • uMI Panvivo, a robust new PET/CT platform
  • uMI Panorama GS, a next-generation, 148cm whole-body PET/CT system
  • uOmnispace, a hospital-grade intelligent post-processing software suite
  • uLinac HalosTx,一体化CT圆形直线加速器
  • uMI Panvivo,强大的新PET/CT平台
  • uMI Panorama GS,下一代148厘米全身PET/CT系统
  • uOmnispace,医院级智能后期处理软件套件

These innovations, with the uMI Panorama molecular imaging solution as a key highlight, have gained international recognition. uMI Panorama has been installed at premier institutions in the United States. And, at the EANM 2024 the European Association of Nuclear Medicine (EANM) annual congress, United Imaging Healthcare launched its next-generation PET/CT system, the uMI Panvivo, which will be unveiled for U.S. audiences at the Radiologic Society of North America annual meeting in Chicago, as part of an innovation launch featuring multiple new products in several modalities.

这些创新,以uMI Panorama分子成像解决方案为重点亮点,已获得国际认可。uMI Panorama已安装在美国的顶尖机构。而在2024年欧洲核医学协会(EANM)年度大会上,联影医疗推出了下一代PET/CT系统uMI Panvivo,并将在芝加哥举行的北美放射学会年会上向美国观众展示,作为一个创新发布的一部分,展示多个新产品的多种模式。

Committed to advancing medical innovation through exceptional R&D capabilities and industry leadership, United Imaging Healthcare was recently honored on the Fortune China Tech 50 for 2024. This prestigious recognition underscores United Imaging Healthcare's role in pioneering healthcare technology and elevating standards in medical imaging and patient care globally.

致力于通过卓越的研发能力和行业领导地位推进医学创新,联影医疗最近荣获2024年《财富》中国科技50强荣誉。这一著名认可强调了联影医疗在开创医疗技术和全球医疗影像及患者护理标准的角色。

*not all products noted are clinically or commercially available in the U.S.

在美国,并非所有产品均已经在临床或商业上可用。

About United Imaging Healthcare

关于联影医疗

At United Imaging Healthcare, we develop and produce advanced medical products, digital healthcare solutions, and intelligent solutions that cover the entire process of imaging diagnosis and treatment. Founded in 2011, our company has subsidiaries and R&D centers across China, the United States, Poland, Dubai, and other parts of the world. With a cutting-edge digital portfolio and a mission of Equal Healthcare for All, we help drive industry progress and bold change. To learn more, visit

在联影医疗,我们开发和生产先进的医疗产品、数字医疗解决方案,以及涵盖影像诊断和治疗整个过程的智能解决方案。我们成立于2011年,公司在中国、美国、波兰、迪拜以及世界其他地区设有子公司和研发中心。凭借前沿的数字产品组合和“平等医疗,服务全人类”的使命,我们推动行业进步和大胆变革。要了解更多,请访问

SOURCE United Imaging Healthcare Co., Ltd.

资讯来源:上海联影医疗股份有限公司

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

想要您公司的新闻在PRNEWSWIRE.COM上特色呈现吗?

440k+
440k+

Newsrooms &
新闻发布室&

Influencers
影响力人士
9k+
9k+

Digital Media
数字媒体

Outlets
Outlets
270k+
270k+

Journalists
新闻记者

Opted In
Opted In
GET STARTED
开始使用
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发